SOA Wealth Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

SOA Wealth Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,045	Closed	-$3K	–	1040
2022 Q2	$3K	Hold	1,045	–	–	﹤0.01%	676
2022 Q1	$4K	Hold	1,045	–	–	﹤0.01%	738
2021 Q4	$4K	Hold	1,045	–	–	﹤0.01%	712
2021 Q3	$4K	Hold	1,045	–	–	﹤0.01%	732
2021 Q2	$4K	Hold	1,045	–	–	﹤0.01%	715
2021 Q1	$4K	Hold	1,045	–	–	﹤0.01%	668
2020 Q4	$7K	Buy	+1,045	New	+$4.47K	﹤0.01%	576

SOA Wealth Advisors's LJPC Position: Q3 2022 in Review

SOA Wealth Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 1,045 shares — an estimated $3K sold.

SOA Wealth Advisors first reported a position in LJPC in Q4 2020 and held it in 7 quarters. The position peaked at $7K in Q4 2020. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

SOA Wealth Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
SOA Wealth Advisors sold 1,045 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $3K.
SOA Wealth Advisors first reported a position in La Jolla Pharmaceutical Company in Q4 2020 and held it in 7 quarters.
SOA Wealth Advisors's La Jolla Pharmaceutical Company position peaked at $7K in Q4 2020.
0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on SOA Wealth Advisors's 13F filing for Q3 2022, filed 7 Oct 2022.